trending Market Intelligence /marketintelligence/en/news-insights/trending/OHEE-w6TR5ywsd3BIiWNmg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Sawai closes acquisition of Upsher-Smith's generics biz

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Sawai closes acquisition of Upsher-Smith's generics biz

Sawai Pharmaceutical Co. Ltd. completed its acquisition of Upsher-Smith Laboratories Inc.'s generic pharmaceuticals business.

The Japanese drugmaker plans to retain operations in Minnesota and Colorado.

Upsher-Smith's current president, Rusty Field, will take on the additional role of CEO.

Torreya Partners LLC and SMBC Nikko Securities Inc. acted as financial advisers to Sawai for the transaction, while Debevoise & Plimpton LLP acted as legal counsel. Upsher-Smith's financial advisers were J.P. Morgan Securities LLC and BMO Capital Markets, while Lindquist & Vennum LLP served as legal counsel.